Tolerability, safety and intermediary pharmacological effects of cilostazol and isosorbide mononitrate, alone and combined, in patients with lacunar ischaemic stroke: The LACunar Intervention-1 (LACI-1) trial, a randomised clinical trial

Authors:

Abstract
No abstract available
Funding Information
  • Alzheimer's Society (AS-PG-14-033)
  • European Union (666881)
  • Stroke Association Princess Margaret Research Development Fellowship scheme
  • Stroke Association Garfield Weston Foundation Senior Clinical Lectureship
  • NHS Research Scotland
  • China Scholarship Council
  • University of Edinburgh
  • NHS Lothian Research and Development Office
  • Row Fogo Charitable Trust
  • Scottish Funding Council
  • Fondation Leducq (16 CVD 05)
  • Edinburgh and Lothians Health Foundation
  • National Institute for Health Research
  • BHF
  • NIHR Clinical Research network (CRN) East Midlands

This publication has 30 references indexed in Scilit: